Literature DB >> 21478284

Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology.

G S Perysinaki1, D K Moysiadis, G Bertsias, I Giannopoulou, K Kyriacou, L Nakopoulou, D T Boumpas, E Daphnis.   

Abstract

Renal podocytes and their slit diaphragms ensure the integrity of the renal basement membrane that forms the barrier to urinary protein loss. A putative disruption of the slit diaphragm and its main protein components, nephrin and podocin, may be implicated in the pathogenesis of lupus nephritis (LN). We studied the glomerular protein expression of nephrin and podocin in NZB/W LN mice by Western blot and immunofluorescence; mRNA levels were measured by real-time PCR. Human kidney biopsies of class II (n = 5), IV (n = 4), V (n = 7) LN were evaluated for nephrin expression by immunohistochemistry. Glomerular protein expression of nephrin and podocin were significantly reduced in NZB/W LN, starting from the earlier stages (mild mesangial LN) and becoming pronounced at advanced histological forms (focal and diffuse proliferative LN). Nephrin and podocin mRNA levels were substantially decreased in diffuse proliferative disease. Decreased expression of both proteins correlated with electron microscopy findings of distorted slit diaphragms. In patients with LN, nephrin was decreased particularly in diffuse proliferative LN. The main slit diaphragm proteins, nephrin and podocin, are affected from the earlier stages of LN and their expression correlates with disease histology. Our findings suggest a novel role of podocytes and their structures in immune-mediated nephritis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478284     DOI: 10.1177/0961203310397412

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  24 in total

Review 1.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

2.  Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis.

Authors:  Dawn J Caster; Erik A Korte; Michael L Merchant; Jon B Klein; Daniel W Wilkey; Brad H Rovin; Dan J Birmingham; John B Harley; Beth L Cobb; Bahram Namjou; Kenneth R McLeish; David W Powell
Journal:  Proteomics Clin Appl       Date:  2015-06-12       Impact factor: 3.494

3.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

Authors:  Tang-Dong Liao; Pablo Nakagawa; Branislava Janic; Martin D'Ambrosio; Morel E Worou; Edward L Peterson; Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-04

4.  Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Authors:  Yumin Xia; Leal C Herlitz; Simona Gindea; Jing Wen; Rahul D Pawar; Alexander Misharin; Harris Perlman; Lan Wu; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

Review 5.  Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics.

Authors:  Guo-Xiang Hao; Lin-Lin Song; Dong-Feng Zhang; Le-Qun Su; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

Review 6.  UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?

Authors:  Ji-Hong Cui; Xin Xie
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

7.  Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.

Authors:  Mariane dos Santos; Rafael N Bringhenti; Patrícia G Rodrigues; Jonathan F do Nascimento; Sane V Pereira; Rafael Zancan; Odirlei A Monticielo; Andrese A Gasparin; Waldir P de Castro; Francisco V Veronese
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

8.  Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.

Authors:  Patrícia Garcia Rodrigues; Rafael Nazário Bringhenti; Jonathan Frapporti do Nascimento; Gabriel Joelsons; Mariane dos Santos; Sane Pereira; Francisco Veríssimo Veronese
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Dexamethasone prodrug treatment prevents nephritis in lupus-prone (NZB × NZW)F1 mice without causing systemic side effects.

Authors:  Fang Yuan; Richard K Nelson; Dana E Tabor; Yijia Zhang; Mohammed P Akhter; Karen A Gould; Dong Wang
Journal:  Arthritis Rheum       Date:  2012-12

10.  Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.

Authors:  Kunihiro Ichinose; Takeshi Ushigusa; Ayako Nishino; Yosikazu Nakashima; Takahisa Suzuki; Yoshiro Horai; Tomohiro Koga; Shin-ya Kawashiri; Naoki Iwamoto; Mami Tamai; Kazuhiko Arima; Hideki Nakamura; Yoko Obata; Kazuo Yamamoto; Tomoki Origuchi; Tomoya Nishino; Atsushi Kawakami; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2016-04       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.